Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
HIV-1 Vif, APOBEC, and intrinsic immunity.
Goila-Gaur R, Strebel K
Retrovirology 2008, 5:51
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%


 Short report    
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity
Pauli EK, Schmolke M, Hofmann H, Ehrhardt C, Flory E, Münk C, Ludwig S
Retrovirology 2009, 6:38 (16 April 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.
36%36%


 Research    
A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR
Zhou T, Han Y, Dang Y, Wang X, Zheng YH
Retrovirology 2009, 6:31 (3 April 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.
36%36%


 Review    
When is it time for reverse transcription to start and go?
Mougel M, Houzet L, Darlix JL
Retrovirology 2009, 6:24 (4 March 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
4.
36%36%


 Research    
APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression
Vázquez-Pérez JA, Ormsby CE, Hernández-Juan R, Torres KJ, Reyes-Terán G
Retrovirology 2009, 6:23 (2 March 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
5.
36%36%


 Research    
APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA
Russell RA, Moore MD, Hu WS, Pathak VK
Retrovirology 2009, 6:16 (13 February 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
6.
36%36%


 Research    
MDM2 is a novel E3 ligase for HIV-1 Vif
Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T
Retrovirology 2009, 6:1 (7 January 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
7.
36%36%


 Commentary    
25 years of HIV-1 research progress and perspectives
Wainberg MA, Jeang KT
BMC Medicine 2008, 6:31 (31 October 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
8.
36%36%


 Research    
APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication
Li L, Liang D, Li J, Zhao RY
Retrovirology 2008, 5:72 (4 August 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
9.
36%36%


 Commentary    
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
Strebel K, Khan MA
Retrovirology 2008, 5:55 (2 July 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 6 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.